As far as the current state of play, these past three weeks we have seen three crucial positive readouts of data from leading programs. The first came from pfizer, the second came from moderna, and the third one this morning just came from astrazeneca and the team at oxford. These are three leading vaccine front runners, all three in late stage studies appear to be effective, the first to 95 effective in preventing covid19. Thatnity is expected to do late november, early december. That will set up an fda decision, all eyes turning to the agency to see how quickly they can approve it and for what subgroups of the population. Vaccineing on in the phase, but there is a lot going on and muchneeded positive news when you think about the surge that we have seen in cases, hospitalizations, and deaths. The fda approval, how quickly could they approve it, and what could keep them from being approved, and how is the fda ensuring confidence in the public in the safety of these vaccines . Guest i
Phone lines split up as usual this morning. Democrats, 202 7488000 is the number to call in. Republicans, 202 7488001. Independents, 202 7488002. You can also send us a text. That number, 202 7488003. If you do, please include your name and where you are from. You can catch up with us on social media, twitter and facebook. A very good monday morning to you. You can start calling in now. Theheadlines on this topic, first use of the vaccine maybe december 13. 40 million doses said to be available by the end of the month. That from the front page of usa today. Frontline gets the first vaccine doses, but then who . Thats the question we are asking this morning, asking you to be in the position of setting the priority, how would you do it . Turning to the cdc webpage there, i q a on how the cdc is making its covid19 vaccine recommendations. Making those disease vaccine recommendations based on the input from the Advisory Committee on immunization practices. Its a federal Advisory Committee
Here on cspan. Is the Health Care Reporter focusing on the pharmaceutical biotech industry for Business Insider and joins us via zoom for a deep dive into the topic of Coronavirus Vaccine. It has been hard to keep up with the news of the past two weeks. Take us through what you expect in the coming days and weeks. What we should be watching for this week. Guest thanks for having me, john. That makes two of us as far as trying to keep on top of everything. As far as the current state of play, these past three weeks we have seen three crucial positive readouts of data from leading programs. The first came from pfizer, the second came from moderna, and the third one this morning just came from astrazeneca and the team at oxford. These are three leading vaccine front runners, all three in late stage studies appear to be effective, the first to 95 effective in preventing covid19. Thatnity is expected to do late november, early december. That will set up an fda decision, all eyes turning to
[background noises] [background noises] welcome everybody to todays hybrid hearing pursuant to house rules some members will appear in person and others will appear remotely via webex. Some members are appearing in person and let me first remind ereveryone that pursuant to the latest guidance on the house attending physician all individuals attending this hearing in person must wear a face mask. Numbers werefa not wearing a may facemask will not be recognized and let me also make a few reminders for those numbers appearing in person, you will see members and witnesses appearing remotely on the monitor in front of you when you are speaking is what is known in web acts as active speaker you. A timer is visible in the room directly in front of you. Members appearing remotely i know youre all familiar with web ex by now but let me remind everyone of a few points. First, you will see each person speaking during the hearing whether in person or remote as long as yous have your web acts set t
Kids spoke with governors from across the u. S. About vaping and ecigarette usage among teenagers. He talked with the governors during the National Governors Association Winter meeting in washington, d. C. We were chatting this morning as governors in an executive committee and talking about how governors at the end of the day have to get a job done. Thats why learning from each other in a bipartisan way is so important. Whether its infrastructure or economic development, there are lessons we can learn. One challenge we all have is Public Health. The vaping crisis that is going all across this nation and is spreading with a frightening facility among our young people. We have two great governors who are going to speak to us about it now. Its my pleasure to introduce governor dewine from ohio and Governor Brown from oregon. Thank you. [ applause ] set our guests up. Good to see you. Thank you. Good afternoon, everyone. Im kate brown, governor of oregon and chair of the nga health and hu